The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort

dc.contributor.author	Uslu, S; Gulle, S; Can, G; Senel, S; Capar, S; Dalkilic, HE; Akar, S; Koca, SS; Tufan, A; Yazici, A; Yilmaz, S; Inanc, N; Birlik, M; Solmaz, D; Cefle, A; Goker, B; Yolbas, S; Krough, NS; Yilmaz, N; Erten, S; Bes, C; Soysal, O; Ozturk, MA; Haznedaroglu, S; Yavuz, S; Direskeneli, H; Onen, F; Sari, I
dc.date.accessioned	2023-03-02T06:39:12Z
dc.date.available	2023-03-02T06:39:12Z
dc.date.issued	SEP
dc.date.issued	2022
dc.identifier.uri	http://hdl.handle.net/20.500.12481/14338
dc.title	The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort
dc.title.alternative	ARTHRITIS & RHEUMATOLOGY
dc.identifier.volume	74
dc.identifier.startpage	847
dc.identifier.endpage	849
dc.identifier.issn/e-issn	2326-5191
dc.identifier.issn/e-issn	2326-5205

Files in this item

Files	Size	Format	View
There are no files associated with this item.